{{Underlinked|date=May 2016}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444411745
| IUPAC_name = 2-[12-(oxiran-2-yl)-2,5,8,11-tetraoxadodecan-1-yl]oxirane
| image = Etoglucid.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =  
| ATC_prefix = L01
| ATC_suffix = AG01
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 460287
| PubChem = 16058
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 4F9KUA0T4D
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07256
|  ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 15246
|  smiles = O(CCOCCOCC1OC1)CCOCC2OC2
|  StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C12H22O6/c1(13-3-5-15-7-11-9-17-11)2-14-4-6-16-8-12-10-18-12/h11-12H,1-10H2
|  StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = UMILHIMHKXVDGH-UHFFFAOYSA-N

<!--Chemical data-->
| chemical_formula =  
| C=12 | H=22 | O=6 
| molecular_weight = 262.29948
| synonyms = <small>diglycidyltriethylene glycol</small>
}}
'''Etoglucid''' is a drug used in [[chemotherapy]].<ref name="pmid8178408">{{cite journal |vauthors=Flamm J, Donner G, Bucher A, Höltl W, Albrecht W, Havelec L |title=[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study] |language=German |journal=Urologe A |volume=33 |issue=2 |pages=138–43 |date=March 1994 |pmid=8178408 |doi= |url=}}</ref>

==References==
{{reflist}}

{{Chemotherapeutic agents}}

[[Category:Antineoplastic drugs]]
[[Category:Epoxides]]
[[Category:Ethers]]


{{antineoplastic-drug-stub}}